High fidelity DNA polymerase compositions and uses thereof

US9181534B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-9181534-B1
Application numberUS-3509101-A
CountryUS
Kind codeB1
Filing dateDec 21, 2001
Priority dateDec 21, 2001
Publication dateNov 10, 2015
Grant dateNov 10, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The subject invention relates to compositions comprising an enzyme mixture which comprises a first enzyme and a second enzyme, where the first enzyme comprises a DNA polymerization activity and the second enzyme comprises an 5′-3′ exonuclease activity and a reduced DNA polymerization activity. The invention also relates to the above compositions in kit format and methods for high fidelity DNA synthesis using the subject compositions of the invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. An enzyme mixture comprising a first enzyme and a second enzyme, wherein said first enzyme is a DNA polymerase or reverse transcriptase, and said second enzyme is the wild type Pfu DNA polymerase comprising the amino acid sequence of SEQ ID NO. 12, except that it is mutated at an amino acid position selected from the group consisting of: Y410, D543, K593, G387, G388, and the following amino acid substitutions: Y385N, Y385W, Y385L, Y385H, Y385Q, and Y385S, and wherein said second enzyme possesses reduced 3′-5′ exonuclease activity and reduced 5′-3′ DNA polymerization activity as compared to the wild type Pfu DNA polymerase. 2. The enzyme mixture of claim 1 , wherein said first enzyme is selected from the group consisting of: Taq DNA polymerase, Tth DNA polymerase, U1Tma DNA polymerase, Tli DNA polymerase (Vent DNA polymerase), Pwo DNA polymerase, Tgo DNA polymerase, Pfu DNA polymerase, KOD DNA polymerase, JDF-3 DNA polymerase having the sequence shown in SEQ ID NO. 10, PGB-D DNA polymerase (Deep Vent DNA polymerase) and DP1/DP2 DNA polymerase. 3. The enzyme mixture of claim 1 , wherein said Pfu DNA polymerase mutations are one or more amino acid substitutions selected from the group consisting of: Y410F, D543G, K593T, Y385Q, Y385S, Y385N, Y385L, Y385H, G387S, G387P, and G388P. 4. The enzyme mixture of claim 1 , further comprising a PCR enhancing factor and/or an additive. 5. A kit comprising a first enzyme, a second enzyme, and packaging material therefor, wherein said first enzyme is a DNA polymerase or reverse transcriptase, and said second enzyme is the wild type Pfu DNA polymerase comprising the amino acid sequence of SEQ ID NO. 12, except that it is mutated at an amino acid position selected from the group consisting of: Y410, D543, K593, G387, and G388, G388, and the following amino acid substitutions: Y385N, Y385W, Y385L, Y385H, Y385Q, and Y385S, and wherein said second enzyme possesses reduced 3′-5′ exonuclease activity and reduced 5′-3′ DNA polymerization activity as compared to the wild type Pfu DNA polymerase. 6. The kit of claim 5 , wherein said first enzyme is selected from the group consisting of: Taq DNA polymerase, Tth DNA polymerase, U1Tma DNA polymerase, Tli DNA polymerase (Vent DNA polymerase), Pwo DNA polymerase, Tgo DNA polymerase, Pfu DNA polymerase, KOD DNA polymerase, JDF-3 DNA polymerase having the sequence shown in SEQ ID NO. 10, PGB-D DNA polymerase (Deep Vent DNA polymerase) and DP1/DP2 DNA polymerase. 7. The kit of claim 5 , further comprising one or more components selected from the group consisting of: a deoxynucleotide, a reaction buffer, a PCR enhancing factor and/or an additive, a control DNA template and a control primer. 8. The kit of claim 5 , wherein said Pfu DNA polymerase mutations are one or more amino acid substitutions selected from the group consisting of: Y410F, D543G, K593T, Y385Q, Y385S, Y385N, Y385L, Y385H, G387S, G387P, and G388P. 9. A method for DNA synthesis comprising: (a) providing said enzyme mixture of claim 1 ; and (b) contacting said enzyme mixture with a nucleic acid template, wherein said enzyme mixture permits DNA synthesis. 10. The method of claim 9 , wherein said nucleic acid template is a DNA molecule. 11. The method of claim 9 , wherein said first enzyme is selected from the group consisting of: Taq DNA polymerase, Tth DNA polymerase, U1Tma DNA polymerase, Tli DNA polymerase, Pfu DNA polymerase, KOD DNA polymerase, JDF-3 DNA polymerase, PGB-D DNA polymerase and DP1/DP2 DNA polymerase. 12. A method for DNA synthesis comprising: (a) providing said enzyme mixture of claim 1 , and (b) contacting said enzyme mixture with a nucleic acid template, wherein said enzyme mixture permits DNA synthesis. 13. The method of claim 9 , wherein said Pfu DNA polymerase mutations are one or more amino acid substitutions selected from the group consisting of: D405E, Y410F, D543G, K593T, Y385Q, Y385S, Y385N, Y385L, Y385H, G387S, G387P, and G388P. 14. An enzyme mixture comprising a first enzyme and a second enzyme, wherein said first enzyme is Taq DNA polymerase, and said second enzyme is the wild type Pfu DNA polymerase comprising the amino acid sequence of SEQ ID NO. 12, except that it is mutated at an amino acid position selected from the group consisting of: Y410, D543, K593, G387, G388, and the following amino acid substitutions: Y385N, Y385W, Y385L, Y385H, Y385Q, and Y385S, and wherein said second enzyme possesses reduced 3′-5′ exonuclease activity and reduced 5′-3′ DNA polymerization activity as compared to the wild type Pfu DNA polymerase. 15. A method for TA cloning of DNA synthesis product comprising: (a) providing the enzyme mixture of claim 14 ; (b) contacting said enzyme mixture with a nucleic acid template, wherein said enzyme mixture permits DNA synthesis to generate a synthesized DNA product; and (c) inserting said synthesized DNA product into a TA cloning vector. 16. The method of claim 9 , 12 or 15 , wherein said reaction mixture further comprises a PCR enhancing factor and/or an additive. 17. The method of claim 12 or 15 , wherein said Pfu DNA polymerase mutations are one or more amino acid substitutions selected from the group consisting of: D405E, Y410F, D543G, K593T, Y385Q, Y385S, Y385N, Y385L, Y385H, G387S, G387P, and G388P. 18. The enzyme mixture of claim 14 , wherein said Pfu DNA polymerase mutations are one or more amino acid substitutions selected from the group consisting of: Y410F, D543G, K593T, Y385Q, Y385S, Y385N, Y385L, Y385H, G387S, G387P, and G388P. 19. The enzyme mixture of claim 14 , wherein said Pfu DNA polymerase is mutated at amino acid position G387. 20. The enzyme mixture of claim 14 , wherein said Pfu DNA polymerase is mutated at amino acid position G387 and the resulting amino acid substitution is G387P. 21. An enzyme mixture comprising a first enzyme and a second enzyme, wherein said first enzyme is KOD DNA polymerase, and said second enzyme is the wild type Pfu DNA polymerase comprising the amino acid sequence of SEQ ID NO. 12, except that it is mutated at an amino acid position selected from the group consisting of: D405, Y410, D543, K593, G387, G388, and the following amino acid substitutions: Y385N, Y385W, Y385L, Y385H, Y385Q, and Y385S, and wherein said second enzyme possesses reduced 3′-5′ exonuclease activity and reduced 5′-3′ DNA polymerization activity as compared to the wild type Pfu DNA polymerase. 22. The enzyme mixture of claim 21 , wherein said Pfu DNA polymerase mutations are one or more amino acid substitutions selected from the group consisting of: D405E, Y410F, D543G, K593T, Y385Q, Y385S, Y385N, Y385L, Y385H, G387S, G387P and G388P. 23. The enzyme mixture of claim 21 , wherein said Pfu DNA polymerase is mutated at amino acid position G387. 24. The enzyme mixture of claim 21 , wherein said Pfu DNA polymerase is mutated at amino acid position G387 and the resulting amino acid substitution is G387P. 25. An enzyme mixture comprising a first enzyme and a second enzyme, wherein said first enzyme is a JDF-3 DNA polymerase having the sequence shown in SEQ ID NO. 10, and said second enzyme is the wild type Pfu DNA polymerase comprising the amino acid sequence of SEQ ID NO. 12, except that it is mutated at an amino acid position selected from the group consisting of: D405, Y410, D543, K593, G387, G388, and the following amino acid substitutions: Y385N, Y385W, Y385L, Y385H, Y385Q, and Y385S, and wherein sa

Assignees

Inventors

Classifications

  • C12N9/1252Primary

    DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

  • C12N9/12Primary

    transferring phosphorus containing groups, e.g. kinases (2.7) · CPC title

  • Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9181534B1 cover?
The subject invention relates to compositions comprising an enzyme mixture which comprises a first enzyme and a second enzyme, where the first enzyme comprises a DNA polymerization activity and the second enzyme comprises an 5′-3′ exonuclease activity and a reduced DNA polymerization activity. The invention also relates to the above compositions in kit format and methods for high fidelity DNA s…
Who is the assignee on this patent?
Hogrefe Holly, Borns Michael, Sorge Joseph A, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12N9/1252. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).